Drugs / Cold-adapted live attenuated influenza virus vaccine, trivalent
Cold-adapted live attenuated influenza virus vaccine, trivalent
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00133523 | Oct 2004 → Jul 2007 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cold-adapted live attenuated influenza virus vaccine, trivalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00133523 ↗ |
| Modality | Vaccine | “Live-attenuated influenza vaccine” NCT00133523 ↗ |
| Route | Intranasal | “single annual dose administered as an intranasal spray.” NCT00133523 ↗ |